Study of AMG 513 for people with obesity
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests an experimental medication called AMG 513 to see how safe it is and how the body processes it. It is for people with obesity who may benefit from a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- Your body mass index (BMI) is between 30 and 40 (for Part A) or between 27 and 40 (for Part B)
- You do not have diabetes (based on blood tests)
- Your triglycerides (a blood fat) are under 500 mg/dL
- For women: you are not able to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This early-stage trial tests a new drug called AMG 127 to see if it's safe and how the body handles it. Researchers will enroll both healthy volunteers and people with type 2 diabetes to understand how the drug works in different groups.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests a new medication called IBI3032 in healthy people and those with overweight or obesity. It aims to see if the drug is safe and how the body processes it.
Hear when a new Cardiometabolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.